Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: Drug combination studies

Jun Xu Li, Caroline Crocker, Wouter Koek, Kenner C. Rice, Charles P. France

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Rationale: Indirect-acting serotonin (5-HT) receptor agonists (e.g., selective 5-HT reuptake inhibitors [SSRI]) stimulate multiple 5-HT receptors, although the role of particular receptors as well as interaction(s) among different receptors in the therapeutic effects of SSRIs is not fully understood. Objectives: Relatively few studies have systematically examined direct-acting agonists in combination. This study examined the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino) tetralin hydrochloride (8-OH-DPAT; 0.01-10.0 mg/kg) and 3-chloro-4-fluorophenyl-4-fluoro-4-([(5-methyl-6- methylamino-pyridin-2-ylmethyl)-amino]-methyl)-piperidin-1-yl-methanone (F13714; 0.01-1.0 mg/kg) and the 5-HT2A receptor agonists 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM; 0.32-10.0 mg/kg) and dipropyltryptamine (DPT; 1.0-32.0 mg/kg), alone and in combination, in rats responding under a fixed ratio schedule of food presentation. Results: When administered alone, each drug decreased the rate of responding in a dose-related manner with the potency order being F13714 > 8-OH-DPAT > DOM > DPT. WAY100635 (5-HT1A receptor antagonist; 0.01-0.1 mg/kg) attenuated the rate-decreasing effects of 8-OH-DPAT and F13714 while MDL100907 (5-HT 2A receptor antagonist; 0.01-0.1 mg/kg) attenuated the rate-decreasing effects of DOM and DPT. Dose addition analysis showed that the interaction between 8-OH-DPAT and F13714, as well as the interaction between DOM and DPT, was additive. In contrast, the interaction between 8-OH-DPAT and DOM, as well as the interaction between F13714 and DOM, was infra-additive. Conclusions: This study shows that for some dose combinations, agonist actions at one 5-HT receptor subtype attenuate agonist actions at another 5-HT receptor subtype; thus, the combined neuropharmacological actions and therapeutic effects of indirect-acting agonists are not likely to be adequately characterized by examining in isolation activity at particular 5-HT receptor subtypes.

Original languageEnglish (US)
Pages (from-to)489-497
Number of pages9
JournalPsychopharmacology
Volume213
Issue number2-3
DOIs
StatePublished - Feb 2011

Keywords

  • Additivity
  • Agonist
  • Antagonist
  • Drug interaction
  • Rat
  • Receptor
  • Schedule-controlling responding
  • Serotonin

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Effects of serotonin (5-HT)<sub>1A</sub> and 5-HT<sub>2A</sub> receptor agonists on schedule-controlled responding in rats: Drug combination studies'. Together they form a unique fingerprint.

  • Cite this